November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
February 7, 2026 - 20:18
Student discusses how modern technology ruins sleep cyclesThe intricate and often detrimental relationship between modern technology and natural sleep patterns was the focus of a recent campus lecture. The presentation, titled “Broken Clocks: How...
February 7, 2026 - 05:07
How new AI technology is helping detect and prevent wildfiresAs wildfire seasons grow longer and more intense, a new wave of artificial intelligence technology is emerging as a critical tool in the early detection and prevention of catastrophic blazes....
February 6, 2026 - 06:57
AI Race Sends Big Tech’s Capital Spending to Stratospheric HighA staggering wave of investment is set to wash over the technology sector as the race to dominate artificial intelligence accelerates. Four of America`s largest tech firms are collectively...
February 5, 2026 - 21:17
Artificial Intelligence Task Force to guide responsible use of emerging technologyA new university-wide initiative is taking shape to navigate the complex landscape of artificial intelligence in academia. An official task force has been established with the primary mission of...